Born in Terni, December 12th, 1966, married.
Degree in Political Sciences at Rome University “La Sapienza”. Master in Health Economics. LSE Course “International Pharmaceutical Business, Healthcare Reforms and Regulation”.
Joined MSD Italia s.r.l. in 1995. Director General of the Fondazione MSD Italia since 2008.
MSD Italia is the Italian subsidiary of the multinational pharmaceutical company Merck & Co. Since 1891, MSD has helped to find new ways to treat and prevent illness — from the discovery of vitamin B1, to the first measles vaccine, to cold remedies and antacids, to the first statins to treat high cholesterol. MSD scientists have also helped develop many products to improve animal health, including vaccines and antibiotics. Today, as a premier research-intensive biopharmaceutical company, MSD is focused on making important scientific advancements within hepatitis C, HIV, diabetes and immuno-oncology. MSD’s vision is to make a difference in the lives of people globally through innovative medicines, vaccines, and animal health products. MSD is committed to being the premier, research-intensive biopharmaceutical company and is dedicated to providing leading innovations and solutions for today and the future. MSD invests annually more than Euro 9 Billion in R&D and 2.5 Billion in CSR activities.